Stock search

Ticker or company name

Compare stocks

Market: US

  • MRKMerck & Co.
  • JNJJohnson & Johnson
  • PFEPfizer

Add stock

Ticker or company

Summary

MRK
Merck & Co.
$144,46Down −2,23%
Year: Up +59%
38/100Ratio would not consider buying
Open stock page
JNJ
Johnson & Johnson
$282,55Down −1,12%
Year: Up +46%
44/100Best scoreRatio would watch
Open stock page
PFE
Pfizer
$28,86Down −0,10%
Year: Up +12%
44/100Best scoreRatio would watch
Open stock page

Verdict

JNJ has the best score (44). JNJ grows revenue the fastest. PFE is the cheapest by forward P/E. JNJ has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckMRK2 ✓ 2 — 4 ✕JNJ2 ✓ 3 — 3 ✕PFE2 ✓ 3 — 3 ✕
P/E vs its history148,542,940,8
P/E vs industry148,542,940,8
Forward P/E18,723,710,5
Revenue growth, YoY+4,9%+7,8%+1,3%
EPS growth, YoY−87,1%−36,4%−59,3%
Net margin3,6%16,2%6,3%
Net debt / EBITDAn/a—n/a—n/a—
Free cash flow$14,7 bn$20,6 bn$11,8 bn
Share count over a year−0,8%+0,8%+0,6%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterMRKTTMJNJTTMPFETTMIndustry medianTTM
P/E TTM ↓Worst: 148,542,9Best: 40,841,8
Forward P/E ↓18,7Worst: 23,7Best: 10,512,4
PEG ↓Worst: 25,7Best: 4,6−5,53,3
P/S TTM ↓5,4Worst: 6,9Best: 2,63,4
EV/EBITDA ↓Worst: 46,128,1Best: 24,024,0
P/FCF ↓24,7Worst: 33,5Best: 14,014,0

Price, %

  • MRKn/a
  • JNJn/a
  • PFEn/a

Returns

Best WorstNo mark — in between

PeriodMRKJNJPFE
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

MRKJNJPFE
Share of “buy”Best: 71%70%Worst: 38%
Beat the forecastBest: 4 of 4Worst: 3 of 4Best: 4 of 4
Average “surprise”Best: +22,4%Worst: +0,5%+11,7%
Insiders over 12 monthssales $70,7 msales $154 mpurchases $2,83 m

Details are on each stock page.